Stockreport

Harrow’s ImprimisRx Subsidiary Receives $34.9 Million Unanimous Jury Verdict Award in ImprimisRx, LLC v. OSRX, Inc.

Harrow, Inc.  (HROW) 
Last harrow, inc. earnings: 11/13 04:21 pm Check Earnings Report
PDF Jury in Trademark Infringement Case Finds in Favor of ImprimisRx NASHVILLE, Tenn.--(BUSINESS WIRE)--Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceut [Read more]